The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Discovery and prevalence of cancer-susceptibility germline mutations (Mts) in patients (Pts) with advanced renal cell carcinoma (aRCC).
 
Maria Isabel Carlo
No Relationships to Disclose
 
Semanti Mukherjee
No Relationships to Disclose
 
Yelena Kemel
Employment - BioReference Laboratories
 
Liying Zhang
No Relationships to Disclose
 
Diana Mandelker
No Relationships to Disclose
 
Joseph Vijai
No Relationships to Disclose
 
Devyn Taylor Coskey
No Relationships to Disclose
 
Nisha Pradhan
No Relationships to Disclose
 
David Michael Hyman
Consulting or Advisory Role - Atara Biotherapeutics; Chugai Pharma; CytomX Therapeutics
Research Funding - AstraZeneca; Puma Biotechnology
 
A. Ari Hakimi
No Relationships to Disclose
 
Jonathan Coleman
Consulting or Advisory Role - Argos Therapeutics
 
Chung-Han Lee
Research Funding - Eisai (Inst); Pfizer (Inst)
 
Darren R. Feldman
Consulting or Advisory Role - Bayer; Gilead Sciences (I); Seagen
Research Funding - Novartis
 
Martin Henner Voss
Honoraria - Novartis
Consulting or Advisory Role - Alexion Pharmaceuticals; Calithera Biosciences; Exelixis; GlaxoSmithKline; Natera; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb; Genentech/Roche; Pfizer
Travel, Accommodations, Expenses - Novartis; Takeda
 
Kenneth Offit
No Relationships to Disclose
 
Mark E. Robson
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca; McKesson
Research Funding - AbbVie (Inst); AstraZeneca (Inst); Biomarin (Inst); Medivation (Inst); Myriad Genetics (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Robert J. Motzer
Consulting or Advisory Role - Eisai; Exelixis; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb